Kodiak Sciences (KOD) Share-based Compensation (2017 - 2026)
Kodiak Sciences (KOD) posted Share-based Compensation of $12.2 million for Q1 2026, down 8.51% on a QoQ basis from $13.3 million in Q4 2025, and down 23.51% year-over-year from $15.9 million in Q1 2025.
Kodiak Sciences (KOD) Share-based Compensation (2017 - 2026) Analysis & Trends
Kodiak Sciences' Share-based Compensation history runs 10 years deep, the most recent figure standing at $12.2 million for Q1 2026.
- Quarterly Share-based Compensation fell 23.51% year-over-year to $12.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.1 million (down 4.45% YoY) and the FY2025 annual result came in at $67.7 million, down 41.49% from the prior year.
- Share-based Compensation was $12.2 million for Q1 2026 at Kodiak Sciences, down from $13.3 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $28.1 million in Q1 2022 and bottomed at $8.6 million in Q4 2024.
- A 5-year average of $19.2 million and a median of $18.4 million in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 183.07% — and 2024, when it plunged 62.25%.
- Kodiak Sciences' Share-based Compensation stood at $25.8 million in 2022, then dropped by 11.44% to $22.8 million in 2023, then plunged by 62.25% to $8.6 million in 2024, then surged by 54.14% to $13.3 million in 2025, then declined by 8.51% to $12.2 million in 2026.
- Business Quant data shows KOD's Share-based Compensation at $12.2 million in Q1 2026, $13.3 million in Q4 2025, and $14.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | 12.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.16 Mn |
| Mar 31, 2026 | 12.16 Mn |
| Dec 31, 2025 | 13.29 Mn |
| Dec 31, 2025 | 13.29 Mn |
| Sep 30, 2025 | 14.05 Mn |
| Sep 30, 2025 | 14.05 Mn |
| Jun 30, 2025 | 15.64 Mn |
| Jun 30, 2025 | 15.64 Mn |
| Mar 31, 2025 | 15.89 Mn |
| Mar 31, 2025 | 15.89 Mn |
| Dec 31, 2024 | 8.62 Mn |
| Dec 31, 2024 | 8.62 Mn |
| Sep 30, 2024 | 14.81 Mn |
| Sep 30, 2024 | 14.81 Mn |
| Jun 30, 2024 | 18.38 Mn |
| Jun 30, 2024 | 18.38 Mn |
| Mar 31, 2024 | 18.41 Mn |
| Mar 31, 2024 | 18.41 Mn |
| Dec 31, 2023 | 22.83 Mn |
| Dec 31, 2023 | 22.83 Mn |